Lucy Scientific Discovery Inc. (LSDI)
LSDIPrice: $0.51
Fair Value: 🔒
🔒score
Lucy Scientific Discovery Inc. researches, develops, manufactures, and commercializes psychedelic products. It offers biological raw materials, crude extracts, psychotropic compounds, and active pharmaceutical ingredients (APIs). Lucy Scientific Discovery Inc. was formerly known as Hollyweed North C... more
Lucy Scientific Discovery Inc. researches, develops, manufactures, and commercializes psychedelic pr... more
Description
Shares
| Market Cap | $906,910 | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | CA | CEO | Richard D. Nanula |
| IPO Date | 2023-02-09 | CAGR | — |
| Employees | 2 | Website | www.lucyscientific.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
LSDI chart loading...
Fundamentals
Technicals
| Enterprise Value | $47.91M | P/E Ratio | -0.07 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 128.68 | P/B Ratio | 1.4 |
| P/CF Ratio | -1.53 | P/FCF Ratio | -0.2 |
| EPS | $-7.64 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | — | Gross Margin | 0.36% |
| Operating Margin | -829.2% | Profit Margin | -1275.32% |
| ROE | 181.47% | ROA | -1.02% |
| ROCE | -0.96% | Current Ratio | 1.41 |
| Quick Ratio | 1.56 | Cash Ratio | 0.62 |
| Debt/Equity | 0.38 | Interest Coverage | -2.97 |
| Altman Z Score | -21.76 | Piotroski Score | 4 |